Glooko raises just under DKK 190m in financing round with Novo Nordisk as major investor

Technology firm Glooko has raised just under DKK 190m to be put towards boosting the company's organic growth. Partner Novo Nordisk is an investor.

Photo: Janus Engel

US software company Glooko has just fetched USD 30m in a new financing round, according to a Tuesday press release. The firm is collaborating with Danish pharmaceutical Novo Nordisk on digital health solutions.

The technology company had a series D financing round led by Health Catalyst Capital with participation from existing investors such as Novo Nordisk.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs